ASPET’s Government Affairs and Science Policy Department is making meaningful progress in strengthening the voice of the pharmacologist community in federal policy conversations.
Advocacy highlights from the ASPET 2025 Annual Meeting.
ASPET Visits Capitol Hill to Support Science Funding During Unprecedented Time
ASPET’s Washington Fellows Program has been educating over 130 early-career pharmacologists since its inception in 2013. The Society’s science policy advocacy program offers early-career pharmacologists the opportunity to immerse themselves in a unique policy learning experience. Regardless of one’s career background, pharmacology fellows learn the basics of science advocacy, participate in Hill Day on Capitol Hill in Washington, D.C. and write a policy brief focusing on a topic of interest.
The Latest Policy News Affecting Scientists: In response to the recent actions taken by the federal government affecting scientists and their research, ASPET leadership released the following statements to its members on January 29th and February 11th, respectively.
Now in its second year, ASPET’s science policy newsletter, Advocacy Brief, helps members keep up with breaking news on policy decisions and legislation affecting biomedical research, research funding opportunities, regulations and other important matters impacting pharmacology and pharmacologists.
This month The Pharmacologist features the final two policy briefs written by participants of the 2024 ASPET Washington Fellows program. These topics present compelling arguments for policy improvements on an issue of personal importance to each Fellow. The policy briefs below discuss racial disparities in maternal mortality and increased PFAS regulations in consumer products.
This month The Pharmacologist features two new policy briefs written by participants of the 2024 ASPET Washington Fellows program. These topics present compelling arguments for policy improvements on an issue of personal importance to each Fellow. The policy briefs below discuss promoting housing among the homeless with substance abuse disorder and the federal legalization of Fentanyl test strips.
This month The Pharmacologist features two new policy briefs written by participants of the 2024 ASPET Washington Fellows program. These topics present compelling arguments for policy improvements on an issue of personal importance to each Fellow. The policy briefs below discuss the importance of understanding polysubstance use and accessible treatments for opioid use disorder in El Paso, Texas.
This month The Pharmacologist features two new policy briefs written by participants of the 2024 ASPET Washington Fellows program. These topics present compelling arguments for policy improvements on an issue of personal importance to each Fellow. The policy briefs below discuss the importance of understanding polysubstance use and accessible treatments for opioid use disorder in El Paso, Texas.
